Forecasts show the global digital therapeutics industry rising at a CAGR of 23.1% with USD 6.9 billion in 2022 and USD 56.7 billion by 2031. Thanks in part to modern healthcare infrastructure and great acceptance of digital health technology, North America dominates the field.
Fast expansion of the digital therapeutics market is being driven by growing healthcare expenses, greater prevalence of chronic illnesses, and more investment in digital health technology. By use of software applications, digital therapies provide evidence-based therapeutic treatments meant to prevent, control, or treat medical illnesses and disorders. The COVID-19 epidemic has sped up the use of digital health technology, thus generating fresh company development prospects.
Integration in market trends of digital technology artificial intelligence and machine learning
Artificial intelligence and machine learning algorithms are progressively included into digital medicines platforms to provide customized treatments and enhance therapeutic results. Predictive modeling, adaptive learning, and real-time data analysis made possible by these technologies let therapeutic methods be optimized depending on particular patient reactions and behaviors. More accurate diagnosis, customized treatment plans, and proactive health management—that is, by means of AI-powered digital therapeutics—may assist to enhance the general effectiveness and user experience of digital health systems.
Market Trend: Rising incidence of chronic conditions and need for reasonably priced treatment alternatives
Digital medicines are in demand as chronic diseases such diabetes, obesity, heart disease, and mental health difficulties become ever more common. These reasonably priced, scalable, easily available alternatives for conventional healthcare delivery systems provide Digital therapies that might provide tools for behavior change, customized treatments, and continuous monitoring to let patients better control their diseases and enhance their health results. Digital medicines provide a potential method to deliver value-based treatment and lower healthcare costs. 55 healthcare systems all over struggle with the increasing burden of chronic illnesses and flirted pricing.
Market Restraint: Restriction pertaining to data security and privacy on digital health systems
Data privacy and security issues define challenges for the general acceptance of digital technology. Large amounts of sensitive personal health data acquired and managed by these technologies generate problems with data security, confidentiality, and most likely use. Under tight regulatory criteria like HIPAA compliance in the United States, digital health services owe great responsibility to protect patient data. Moreover, extensively documented data thefts in the healthcare industry have led to distrust of the security of digital health solutions. Strong cybersecurity policies, open data governance concepts, and regulatory compliance assist to overcome these issues thus fostering public use of digital technologies and establishing confidence.
The market would be largely dominated by sections on software; digital therapeutics solutions based on software steer market development.
Thanks to the development and acceptance of mobile apps, web-based platforms, and cloud-based therapeutic intervention solutions, the software sector is likely to take center stage in the digital therapeutics market. Greater ease of updating, scalability, and flexibility than hardware-based solutions allow software-based digital pharmaceuticals. These programs are more readily available to a larger user base as they may be rapidly disseminated via app stores and linked with present devices. Rising smartphone acceptability and developments in mobile health technology help to explain the frequency of software-based digital therapeutics in many other therapeutic domains.
Leading the market in digital technologies is North America.
Driven by traits like modern healthcare infrastructure, great digital literacy, and a favorable regulatory environment, North America is positioned to rule the worldwide digital therapeutics industry. Digital health technology has led to field investments; value-based care approaches are underlined here more and more. Particularly the United States leads in the use of digital technology as FDA tries to expedite the approval procedure for digital health goods. Leading digital health startups, technological behemoths, and pharmaceutical firms endorsing digital medicines help even more to shape the market leadership of the area. Furthermore, the increasing prevalence of chronic illnesses and growing healthcare expenses in North America suit the atmosphere for the acceptance of reasonably priced digital therapeutic options.
Great competition and fast innovation define the digital therapeutics market. Prominent companies like Pear Therapeutics, Omada Health, Livongo Health—now part of Teladoc Health—keep extending their product lines and market reach. To penetrate the digital medicine market, pharmaceutical corporations are also progressively forming partnerships with or acquisitions of digital health startups. Using their knowledge of data analytics and user experience design, technological giants like Apple, Google, and Amazon are also significantly investing in digital health. As multiple mergers and acquisitions meant to increase capability and market reach show, the industry is moving toward consolidation. Emerging businesses focusing cutting-edge technology or particular treatment areas aspire to stand out in this very competitive industry. Driving adoption and getting reimbursement in the mature sector primarily depends on interactions among digital therapies firms, healthcare providers, and payers.
- Omada Health
- Livongo Health (Teladoc Health)
- Pear Therapeutics
- Welldoc
- Propeller Health
- Noom
- Akili Interactive
- Happify Health
- Click Therapeutics
- Big Health
- Kaia Health
- Cognoa
Teladoc Health bought Livongo Health in a $18.5 billion deal in 2022 to build a whole virtual care platform including digital medical solutions after FDA approval of Pear Therapeutics' prescription digital therapy for those 22 years of age and above for persistent insomnia in 2023
1. INTRODUCTION
1.1. Market Definition
1.2. Study Scope
1.3. Currency Conversion
1.4. Study Period (2022- 2031)
1.5. Regional Coverage
2. RESEARCH METHODOLOGY
2.1. Primary Research
2.2. Secondary Research
2.3. Company Share Analysis
2.4. Data Triangulation
3. EXECUTIVE SUMMARY
3.1. Global Digital Therapeutics Market (2018 – 2022)
3.2. Global Digital Therapeutics Market (2023 – 2031)
3.2.1. Market Segment By Application (2023 – 2031)
3.2.2. Market Segment By End User (2023 – 2031)
3.2.3. Market Segment By Product Type (2023 – 2031)
3.2.4. Market Segment By Sales Channel (2023 – 2031)
4. MARKET DYNAMICS
4.1. Market Trends
4.1.1. Integration of artificial intelligence and machine learning in digital therapeutics
4.1.2. Increased focus on mental health and behavioral therapy solutions
4.1.3. Growing partnerships between digital therapeutics companies and pharmaceutical firms
4.2. Market Drivers
4.2.1. Rising prevalence of chronic diseases and need for cost-effective treatment options
4.2.2. Advancements in mobile health technologies and wearable devices
4.2.3. Shift towards value-based care and preventive healthcare models
4.3. Market Restraints
4.3.1. Concerns over data privacy and security in digital health platforms
4.3.2. Regulatory challenges and reimbursement issues
4.4. Porter's Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Bargaining Power of Buyers/Consumers
4.4.3. Bargaining Power of Suppliers
4.4.4. Threat of Substitute Products
4.4.5. Intensity of Competitive Rivalry
4.5. Supply Chain Analysis
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Pipeline Analysis
5. BY APPLICATION (MARKET VALUE (US$ MILLION) – 2022-2031*)
5.1. Diabetes
5.2. Obesity
5.3. Cardiovascular Diseases
5.4. Central Nervous System (CNS) Diseases
5.5. Respiratory Diseases
5.6. Smoking Cessation
5.7. Others
6. BY END USER
6.1. Patients
6.2. Providers
6.3. Payers
6.4. Employers
7. BY PRODUCT TYPE
7.1. Software
7.2. Devices
8. BY SALES CHANNEL
8.1. Business-to-Business (B2B)
8.2. Business-to-Consumer (B2C)
9. GEOGRAPHY
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Rest of South America
9.3. Europe
9.3.1. Germany
9.3.2. United Kingdom
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle-East
9.5.1. UAE
9.5.2. Saudi Arabia
9.5.3. Turkey
9.5.4. Rest of Middle East
9.6. Africa
9.6.1. South Africa
9.6.2. Egypt
9.6.3. Rest of Africa
10. COMPETITIVE LANDSCAPE
10.1. Key Developments
10.2. Company Market Share Analysis
10.3. Product Benchmarking
11. SWOT ANALYSIS
12. COMPANY PROFILES
12.1. Omada Health
12.2. Livongo Health (Teladoc Health)
12.3. Pear Therapeutics
12.4. Welldoc
12.5. Propeller Health
12.6. Noom
12.7. Akili Interactive
12.8. Happify Health
12.9. Click Therapeutics
12.10. Big Health
12.11. Kaia Health
12.12. Cognoa
13. MARKET OPPORTUNITIES
By End User:
By Product Type:
By Sales Channel:
By Region:
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511
